MobiHealth News November 18, 2021
Laura Lovett

This comes roughly two years after Ro inked a deal with Plenity creator Gelesis.

Ro is taking bets on the weight loss industry with a $30 million prepaid order of diet pill Plenity. The New York-based company inked a deal with Plenity creator Gelesis in 2019 to offer the product as part of Ro’s virtual care services.

Plenity, which was cleared by the FDA in 2019 as a Class II Medical Device, comes in the form of an ingestible capsule. While users can tap into Ro’s telemedicine to get a prescription for the product, Gelesis clarifies that the product is not a drug.

Users can take the capsules before meals with water in order to feel fuller. The product...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, Health IT, Investments, Provider, Technology, Telehealth, Trends, Wellness
EHDS Series - 4: The European Health Data Space’s Implications for “Wellness Applications” and Medical Devices
Wellness remains top priority in senior living, bridging gap between hospitality, medical models
Walmart Aims to Regain Healthcare Lead Over Amazon
A Guide for Specialty Practices Navigating a Future of Healthcare that Does Good and Feels Good
Workout training startup Volt Athletics acquires ZAMA Health

Share This Article